Neuroendocrine tumours trials in Hungary

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Where

  Budapest

  Age

  12 years and over

  People

  355 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT04924075 · EU 2023-504853-11-00
• Phase 3Taking people
  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  Where

  Budapest XII

  Age

  18 years and over

  People

  134 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
• Phase 3Taking people
  Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

  Where

  Budapest VIII, Szeged

  Age

  12 years to 100 years

  People

  240 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06784752 · EU 2024-518325-15-00
• Phase 3Taking people
  Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)

  Where

  Budapest XII, Gyöngyös, Törökbálint

  Age

  18 years and over

  People

  156 worldwide

  Run by

  Amgen Inc.

  See details and how to join2024-520050-38-00 · EU 2024-520050-38-00